GLP-1 receptor agonists increase hormones that help control hunger, satiety and blood sugar. They boost the release of insulin in the body when blood sugar rises, reduce glucagon (a hormone that ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

U.S. airline companies stand to save hundreds of millions each year from Americans losing weight thanks to GLP-1 drugs, ...

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk.

By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

As GLP-1 use rises among women, doctors warn stopping the drugs before pregnancy may trigger weight regain, metabolic rebound and fertility shifts, raising risks of gestational diabetes and ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

The weight loss drug boom could drive fuel costs down.

You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar ...

GLP-1 drugs are forcing companies to adapt to a sustained shift in consumer behavior and healthcare demand that touches both ...